Results 41 to 50 of about 6,905 (159)

Human Metapneumovirus[Hmpv]

open access: yesInternational Journal of Pharmaceutical Research and Applications
Since its discovery in 2001, human metapneumovirus (hMPV) has been found all over the world . A frequent respiratory pathogen particularly in infants and small children, is hMPV. The virus may provoke asthma and is linked to upper and lower respiratory tract infections.
Nandini Sutar Nandini Sutar   +3 more
openaire   +1 more source

Financial Volatility Spillovers and Risk Dynamics in Global Tourism: Evidence From Equity and Bond Markets

open access: yesThunderbird International Business Review, Volume 68, Issue 2, Page 209-237, March/April 2026.
ABSTRACT This study explores the financial volatility and asset interdependence in the global tourism sector by examining spillover dynamics between tourism equities and both green and non‐green financial assets from global stock and bond markets.
Md. Nahiduzzaman   +4 more
wiley   +1 more source

An Unusual Resurgence of Human Metapneumovirus in Western Australia Following the Reduction of Non-Pharmaceutical Interventions to Prevent SARS-CoV-2 Transmission

open access: yesViruses, 2022
Non-pharmaceutical interventions (NPIs) to reduce SARS-CoV-2 transmission disrupted respiratory virus seasonality. We examined the unusual return of human metapneumovirus (hMPV) in Western Australia following a period of absence in 2020. We analysed hMPV
David Anthony Foley   +8 more
doaj   +1 more source

ZNRD2 Mediated Nucleoprotein Aggregation Impairs Respiratory Syncytial Virus Replication

open access: yesAdvanced Science, Volume 13, Issue 12, 27 February 2026.
During RSV infection, nucleoprotein (N) forms RNA‐bound oligomers. The host protein ZNRD2 binds to these oligomers, promoting their transition into insoluble aggregates. These aggregates simultaneously sequester functional N to restrict viral production and disrupt chaperonin assembly quality control by interfering with ZNRD2's role as an adaptor ...
Haiwu Zhou   +8 more
wiley   +1 more source

Nanozymes Integrated Biochips Toward Smart Detection System

open access: yesAdvanced Science, Volume 13, Issue 11, 23 February 2026.
This review systematically outlines the integration of nanozymes, biochips, and artificial intelligence (AI) for intelligent biosensing. It details how their convergence enhances signal amplification, enables portable detection, and improves data interpretation.
Dongyu Chen   +10 more
wiley   +1 more source

Interleukin-1β promotes human metapneumovirus replication via activating the cGAS-STING pathway

open access: yesVirus Research
Background: Human metapneumovirus(hMPV) is one of the most common viruses that cause acute lower respiratory tract infections. Interleukin-1β (IL-1β) has been reported to play an important role in multiple virus replication.
Guojin Wu   +5 more
doaj   +1 more source

Clinical Analysis of Neonatal Influenza in the Neonatal Intensive Care Unit: A Retrospective Study

open access: yesImmunity, Inflammation and Disease, Volume 14, Issue 2, February 2026.
ABSTRACT Background To describe the clinical characteristics, treatment, and outcomes of neonatal influenza. Methods Retrospectively analyzed clinical data on 26 neonates who were diagnosed with neonatal influenza by positive influenza nasopharyngeal swab antigen tests, and admitted to the neonatal intensive care unit of Sichuan Province Chengdu ...
Min Zhou   +5 more
wiley   +1 more source

Small Animal Models for Human Metapneumovirus: Cotton Rat is More Permissive than Hamster and Mouse

open access: yesPathogens, 2014
Human metapneumovirus (hMPV) is the second most prevalent causative agent of pediatric respiratory infections worldwide. Currently, there are no vaccines or antiviral drugs against this virus.
Yu Zhang, Stefan Niewiesk, Jianrong Li
doaj   +1 more source

Molecular epidemiology of human metapneumovirus (hMPV) in Cambodia [PDF]

open access: yesBMC Proceedings, 2011
Background First identified in 2001, human metapneumovirus (hMPV) is a novel pathogen and causative agent of acute respiratory tract infection. Re-infection with hMPV is common, and currently there is no available vaccine against this virus. Two genetic subgroups (A and B) have been identified, both of which can be divided further into at least two ...
Arnott, Alicia   +3 more
openaire   +1 more source

Accelerate the Highly Efficient Development of mRNA Vaccines Through Advanced Computational Methods

open access: yesMedComm, Volume 7, Issue 2, February 2026.
This review explores the recent advancements in applying computational methods to optimize mRNA vaccines, with a primary focus on improvements in sequence design and delivery systems. ABSTRACT mRNA medicine is an emerging therapeutic approach that utilizes messenger RNA to synthesize functional proteins directly within target cells.
Ruichu Gu   +5 more
wiley   +1 more source

Home - About - Disclaimer - Privacy